Cibus, Inc. (NASDAQ:CBUS) Short Interest Update

Cibus, Inc. (NASDAQ:CBUS - Get Free Report) saw a significant decline in short interest in the month of October. As of October 15th, there was short interest totalling 1,850,000 shares, a decline of 9.3% from the September 30th total of 2,040,000 shares. Based on an average daily volume of 198,900 shares, the days-to-cover ratio is currently 9.3 days. Currently, 10.0% of the shares of the company are short sold.

Wall Street Analyst Weigh In

CBUS has been the subject of several analyst reports. Canaccord Genuity Group reaffirmed a "buy" rating and set a $20.00 price objective on shares of Cibus in a research note on Tuesday, October 22nd. Canaccord Genuity Group upgraded Cibus to a "strong-buy" rating in a research note on Friday, July 19th. Finally, Alliance Global Partners lowered their price objective on shares of Cibus from $25.00 to $23.50 and set a "buy" rating on the stock in a research report on Tuesday, September 24th.

Institutional Investors Weigh In On Cibus

Several institutional investors have recently made changes to their positions in CBUS. Vanguard Group Inc. lifted its stake in shares of Cibus by 3.7% in the first quarter. Vanguard Group Inc. now owns 721,945 shares of the company's stock valued at $16,215,000 after purchasing an additional 26,017 shares during the period. Bank of New York Mellon Corp acquired a new stake in shares of Cibus during the 2nd quarter valued at approximately $529,000. Rhumbline Advisers purchased a new stake in shares of Cibus during the 2nd quarter worth approximately $221,000. FineMark National Bank & Trust grew its holdings in shares of Cibus by 24.3% in the 2nd quarter. FineMark National Bank & Trust now owns 20,488 shares of the company's stock worth $202,000 after acquiring an additional 4,000 shares during the period. Finally, Old West Investment Management LLC grew its holdings in shares of Cibus by 3.6% in the 2nd quarter. Old West Investment Management LLC now owns 53,247 shares of the company's stock worth $524,000 after acquiring an additional 1,868 shares during the period. 33.81% of the stock is currently owned by hedge funds and other institutional investors.

Cibus Stock Performance

NASDAQ:CBUS traded down $0.09 during mid-day trading on Wednesday, reaching $4.07. The stock had a trading volume of 107,498 shares, compared to its average volume of 135,203. Cibus has a twelve month low of $2.86 and a twelve month high of $23.18. The business has a 50 day simple moving average of $4.52 and a 200 day simple moving average of $9.39. The firm has a market capitalization of $87.69 million, a price-to-earnings ratio of -0.23 and a beta of 1.81.

Cibus (NASDAQ:CBUS - Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($1.14) EPS for the quarter, missing the consensus estimate of ($0.81) by ($0.33). Cibus had a negative net margin of 9,856.84% and a negative return on equity of 29.05%. The business had revenue of $0.84 million during the quarter, compared to analyst estimates of $0.44 million. During the same period in the prior year, the business earned ($3.05) earnings per share. As a group, sell-side analysts expect that Cibus will post -3.84 earnings per share for the current year.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.